BB3

· Angion Biomedica Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BB3, covering 2014-11-04 to 2014-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack [Phase 2]